Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00724750 · ClinicalTrials.gov registry record · NA

Comparison of Two Methods of Negative Pressure Wound Therapy

A NA study of Acute Wounds From Trauma and Dehiscence or Surgical Complications, sponsored by University of Chicago.

Completed
Registry status
NA
Development phase
87
Enrollment target
1
Study location

NCT00724750: Completed NA study of Acute Wounds From Trauma and Dehiscence or Surgical Complications, sponsored by University of Chicago.

NCT00724750 is a NA study of Acute Wounds From Trauma and Dehiscence or Surgical Complications that has completed, run by University of Chicago. The registered enrollment target is 87 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00724750, a NA study of Acute Wounds From Trauma and Dehiscence or Surgical Complications, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
NA
Development phase
87 participants
Enrollment target
1
Study location

Study Summary

The current standard for negative pressure wound therapy is the Vacuum Assisted Closure Device (VAC), a commercial system that utilizes a computerized suction pump to apply negative pressure to an open-cell poly-urethane foam dressing sealed over a wound. The VAC system is effective but has some drawbacks: * The system is expensive. * There us conflicting data about the effectiveness of VAC therapy for infected wounds. * VAC therapy is difficult to use (and frequently fails) in wounds with excess fluid drainage, and in wounds near body orifices. Over the past 4 years, we have accumulated additional experience with negative pressure wound therapy using wall suction applied to sealed gauze dressings with about 30 patients. We call this method G-SUC and have used it when we have been unable to maintain a dressing seal with the VAC system (due to excess drainage or wound location), for management if infected wounds. We have found this method to be effective without any specific negative side effects. Our specific aims are: 1. Compare the effectiveness of G-SUC and standard VAC therapy. Outcomes measured for each method will include the proportional change in wound size over 1 - 2 weeks. 2. Compare the effectiveness of G-SUC and VAC system in controlling wound infections as measured by the number of patients who are able to clear infection by 4 days. 3. Compare the failure of each method of therapy by documenting the number of dressing that cannot be maintained because of fluid or suction. 4. Measure and compare the cost of wound treatment with the two methods including direct cost and time spent at the bed side performing the dressing change. Our hypotheses are: 1. G-SUC and VAC are equivalent for the treatment of uncomplicated wounds in the acute care, in-patient setting. 2. G-SUC is more effective than VAC for management of infected wounds. 3. G-SUC is more versatile than VAC, and functional G-SUC dressings can be maintained in situations where functional VAC dr

Primary Outcome

Wound surface area was measured daily. The percent change from Day 1 was calculated. A negative value indicates a decrease.

Interventions

  • DEVICE Gauze suction (G-SUC)
  • DEVICE Vacuum Assisted Closure Device (VAC)

Study Locations (1)

Illinois

  • University of Chicago Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 87 participants
Start Date 2006-07
Est. Completion 2008-05
Phase NA
University of Chicago

796 total trials

What the finished NCT00724750 record still lists

NCT00724750 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 87 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 2 conditions, with Acute Wounds From Trauma appearing as the primary indexed condition, and to 2 interventions - of which Gauze suction (G-SUC) is the first listed.

NCT00724750 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT00724750 about?

NCT00724750 is a clinical study titled "Comparison of Two Methods of Negative Pressure Wound Therapy". The current standard for negative pressure wound therapy is the Vacuum Assisted Closure Device (VAC), a commercial system that utilizes a computerized suction pump to apply negative pressure to an open-cell poly-urethane foam dressing sealed over a wound. The VAC system is effective but has some dra...

What is the current status of trial NCT00724750?

This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2006-07. Estimated completion is 2008-05.

What conditions does trial NCT00724750 study?

This clinical trial studies the following conditions: Acute Wounds From Trauma, Dehiscence or Surgical Complications.

What interventions are being tested in trial NCT00724750?

The interventions under investigation include: Gauze suction (G-SUC) (DEVICE), Vacuum Assisted Closure Device (VAC) (DEVICE).

Who is sponsoring clinical trial NCT00724750?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00724750 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT00724750's enrollment target sits among peer trials

87 974th of 2000 higher than 1,025 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03292601 · 87 participants · NA

    Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)

  • NCT04291105 · 87 participants · Phase 2

    Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

  • NCT04565795 · 87 participants · NA

    Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy

  • NCT05607004 · 87 participants · Phase 2

    (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00724750, the US trial registry maintained by the National Library of Medicine. NCT00724750 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.